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ABSTRACT We previously reported the synthesis and structural characterization of a model membrane protein comprised of
an amphiphilic 4-helix bundle peptide with a hydrophobic domain based on a synthetic ion channel and a hydrophilic domain with
designed cavities for binding the general anesthetic halothane. In this work, we synthesized an improved version of this halo-
thane-binding amphiphilic peptide with only a single cavity and an otherwise identical control peptide with no such cavity, and
applied x-ray reﬂectivity to monolayers of these peptides to probe the distribution of halothane along the length of the core of
the 4-helix bundle as a function of the concentration of halothane. At the moderate concentrations achieved in this study, approx-
imately three molecules of halothane were found to be localized within a broad symmetric unimodal distribution centered about
the designed cavity. At the lowest concentration achieved, of approximately one molecule per bundle, the halothane distribution
became narrower and more peaked due to a component of ~19A˚ width centered about the designed cavity. At higher concen-
trations, approximately six to seven molecules were found to be uniformly distributed along the length of the bundle, correspond-
ing to approximately one molecule per heptad. Monolayers of the control peptide showed only the latter behavior, namely
a uniform distribution along the length of the bundle irrespective of the halothane concentration over this range. The results
provide insight into the nature of such weak binding when the dissociation constant is in the mM regime, relevant for clinical appli-
cations of anesthesia. They also demonstrate the suitability of both the model system and the experimental technique for addi-
tional work on the mechanism of general anesthesia, some of it presented in the companion parts II and III under this title.
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The mechanism of general anesthesia defies elucidation
despite more than a century and a half of practical applica-
tion. A variety of small molecules are capable of producing
the anesthetic effect, undermining any apparent structure-
activity relationship (1). Their most notable common charac-
teristic is the way in which their anesthetic potency correlates
with their solubility in nonpolar media, long known as the
Meyer-Overton Rule, and pointing to membranes as the
site of anesthetic action (2). Although indirect mechanisms
continue to be proposed, there is growing evidence for
a direct mechanism, in which anesthetics interact with
specific sites in membrane proteins (3). The putative targets
are ligand-gated ion channels central to neurological signal
transmission (3). The three-dimensional structure of one
representative ligand-gated ion channel, the acetylcholine
receptor, is now known from cryo-electron microscopy
studies (4), but structural information regarding its interac-
tion with an anesthetic may continue to present a challenge
to both electron microscopy and x-ray crystallography,
because only relatively weak binding of the anesthetic char-
acterized by a submillimolar dissociation constant is of phys-
iological relevance (1,5). This lack of structural information
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An alternative approach to studying protein/anesthetic
interactions is the use of model proteins, so-called maquettes,
namely synthetic peptides based on simple and robust struc-
tural motifs (6), which may be designed with cavities for
binding anesthetics (7). The first implementation of this
strategy used amphipathic a-helical peptides generated by
a heptad-repeat patternwith amajority of hydrophilic residues
and aminority of hydrophobic residues. After homodimeriza-
tion, the dihelical units assembled in an antitopology to form
soluble 4-helix bundles with the hydrophobic residues buried
in the core of the bundle. The replacement of a bulkier Leu
residue with a smaller Ala residue at a selected site in the
primary sequence located in the bundle’s interior coupled
with the antitopology of the bundle resulted in two cavities
capable of binding the representative anesthetic halothane
(F3CCBrClH) with a dissociation constant of 0.7 mM (7),
near the clinically relevant range, with the halothane titration
monitored by fluorescence quenching of Trp residues adja-
cent to the designed binding cavities. Subsequent optimiza-
tion of the sequence further reduced the dissociation constant
to 200 mM (8), closely matching the clinically effective
concentration of halothane (EC50 ¼ 250 mM). NMR studies
of this optimized soluble peptide recently yielded the solution
structure of this peptide in the presence of one halothane per
bundle, revealing that the halothane was bound, however, in
an unexpected location in the center of the bundle between
doi: 10.1016/j.bpj.2009.01.053
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designed binding cavities located nearer each end of the
bundle (9). Although further work continues on such water-
soluble bundles, they have inherent limitations that will
prevent them from mimicking many of the properties of
ligand-gated ion channels.
This work results from a different implementation of the
maquette peptide approach using amphiphilic 4-helix bundles
(10). The design was based on that of the soluble anesthetic-
binding 4-helix bundle, with the sequence extended by two
heptads possessing a majority of hydrophobic residues and
a minority of hydrophilic residues. The resulting a-helices
are covalently homodimerized and assemble to form 4-helix
bundles with a syn topology, making the exterior of one end
of the bundle hydrophilic and the exterior of the other end
hydrophobic. We designated the peptide hbAP0 (halothane-
binding amphiphilic peptide 0). Within the hydrophilic
domain of the bundle, each helix has a Trp residue with an
Ala residue at an interior position on either side of the Trp,
so that, like its soluble predecessor, two cavities for binding
anesthetics are formed. Within the hydrophobic domain of
the bundle, the majority hydrophobic sequence is inspired
by a synthetic ion channel (11), hence the amphiphilic anes-
thetic-binding peptide is designed to be a model ion channel;
although this functionality has not yet been demonstrated.
Several demonstrated properties of the amphiphilic peptide
bundle make it an interesting model system. First, the peptide
binds halothane, albeit with a dissociation constant of ~3mM,
somewhat larger than that of the soluble peptide. Second, the
amphiphilic peptide bundles can be spread from methanol
solution to form Langmuir monolayers at the air/water inter-
face in the absence of lipid (10). Third, x-ray reflectivity
measurements showed that the application of surface pressure
could orient the ensemble of peptide molecules with the
a-helices oriented normal to the air/water interface (10).
Fourth, x-ray scattering measurements verify that the peptide
maintains its 4-helix coiled-coil structure at the air-water
interface (12). On the strength of these advantages, we sought
to follow up our earlier structural investigations of the apo
peptide with a structural study of the peptide interacting
with halothane.
Because of the high electron density of the halogen-rich
halothane molecule, we expected it would have sufficient
contrast relative to peptide and water that its presence within
a Langmuir monolayer should be observable by x-ray reflec-
tivity measurements. Because the orientation of the peptide
bundles at high surface pressures essentially maps the
sequence of amino acids onto the coordinate axis normal to
the air/water interface, the direction probed by x-ray reflectiv-
ity, we expected to be able to determine the location of any
halothane bound to the bundle and infer which amino-acid
residues interact with the halothane. For this purpose, we
synthesized a new amphiphilic halothane-binding peptide by
making two substitutions in the sequence of the first peptide
(10).Our newpeptide, hbAP1, is hbAP0(A8L,L22M). PuttingLeu at position 8 removes one of the binding cavities in the
bundle, leaving only a single binding site, Ala19 , facilitating
interpretation of the results. IntroducingMet allows for future
labeling experiments with Se-Met. We also synthesized a
control peptide, hbAP1(A19L), which has no designed cavity
for binding halothane. As a preliminary to our x-ray reflecti-
vity study of monolayers of these peptides in the presence of
halothane, we report the characterization of these peptides
solubilized in aqueous buffer with the aid of detergent and at
the air/water interface in the absence of halothane. The results
show hbAP1 has an affinity for halothane (Kd ¼ 2.5 mM),
similar to that of hbAP0. Just like hbAP0, the peptides form
stable monolayers at the air/water interface above an aqueous
subphase, can be similarly oriented through the application of
surface pressure, andmaintain their 4-helix coiled-coil confor-
mation at the air/water interface. But our main purpose here is
to report on x-ray reflectivity measurements conducted on
Langmuir monolayers of these peptides in equilibrium with
a gaseous superphase containing halothane vapor.
Amajority of thiswork concerns x-ray reflectivitymeasure-
ments to study the dissociation of halothane fromour peptides.
In brief, we formed Langmuir monolayers of the vectorially
oriented halothane-binding peptide hbAP1 or of the vectori-
ally oriented control peptide hbAP1(A19L) without the
designed binding cavity. For each monolayer, we collected
x-ray reflectivity data in the absence of the anesthetic, after
introduction ofmaximal halothane vapor in the gaseous super-
phase above the monolayer, and subsequently after stepwise
purges of the halothane from the monolayer system that
reduced the atmospheric concentration of halothane back to
zero. The reflectivity data showed significant, reproducible
effects due to the presence of halothane that were mostly
reversible. We applied a model-independent means of anal-
ysis to obtain themonolayer profile structure, the average elec-
tron-density distribution projected onto the coordinate axis
normal to the air/water interface, for each monolayer under
the different concentrations of halothane. The results for the
hbAP1 peptide in these dissociation experiments achieved
only moderate concentrations of three to four halothanemole-
cules per bundle. However, they provide evidence for locali-
zation of the halothane within a broad symmetric unimodal
distribution centered on the site of the designed cavity,
whereas at higher concentrations the distribution becomes
spread uniformly along the entire length of the bundle. Recent
experiments investigated the ‘‘association’’ of halothane with
the peptides, exposing the monolayer to minimal halothane
concentrations in the superphase followed by a purge to
zero halothane, and achieved lower concentrations of about
one halothanemolecule per bundle. In this case, the halothane
distribution became narrower and more peaked due to
a component of only ~19 A˚ width centered about the designed
cavity. In the monolayers of the control peptide, the distribu-
tion of halothane remains uniformly distributed along the
length of the bundle failing to become localized at any concen-
tration of halothane in both the dissociation and associationBiophysical Journal 96(10) 4164–4175
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weak bindingwhen the dissociation constant of the interaction
is in the mM range. The consequences for understanding
anesthesia and the prospects for future studies are discussed.
The demonstrated utility of these oriented model protein
systems has already lead to complementary studies by fluores-
cence and polarized infrared spectroscopy (13) and correlated
molecular dynamics simulations (14) appearing in the
companion parts II and III under this title.
METHODS
Peptides
hbAP0
Ac-LKKLREE AAKLFEE WKKLAEE LLLLALL QLLLALL QLGGC-
CONH2
hbAP1
Ac-LKKLREE LAKLFEE WKKLAEE MLLLALL QLLLALL QLGGC-
CONH2
hbAP1(A19L)
Ac-LKKLREE LAKLFEE WKKLLEE MLLLALL QLLLALL QLGGC-
CONH2
The peptides with amino-acid sequences and names given above were
prepared by solid phase synthesis with Fmoc chemistry as described previ-
ously (10). After dimerization via theC-terminalCys residues, the lyophilized
powder was dissolved in pure methanol at ~100 mM concentration of
a-helices. The peptide hbAP0has two designed cavities for binding halothane
at the sites where Alanine is interior to the bundle (positions 8 and 19),
hbAP1 has only one designed cavity for binding halothane (Ala19), whereas
hbAP1(A19L) is the control peptide with no designed cavity for binding
halothane. The substitution L22/M in hbAP1 will allow future labeling
with Se-Met to enable resonant x-ray reflectivity measurements (15) that
could be used to more precisely determine the position of the cavity along
the length of the bundle within the electron-density profile derived from the
reflectivity data.
Halothane system
Data were collected in three separate synchrotron runs. In each run, the
sample stage of the liquid surface spectrometer held a gastight canister con-
taining the Langmuir trough. A large kapton window permitted the incident
and scattered x-ray beams to penetrate the canister. A system of Teflon
tubing and valves permitted the air in the canister to be purged with moist
helium, as monitored by an oxygen sensor in the canister (S101, QUBIT
Systems, Kingston, ON, Canada). Then the canister could be connected to
a closed loop including a diaphragm pump that forced the helium through
liquid halothane in a glass washing bottle, vaporizing the halothane and
causing its concentration in the gas phase to increase with time. Before
use, liquid halothane (Sigma-Aldrich) was filtered on an alumina column
to remove the preservative thymol. A portable UV-vis spectrophotometer
(SD 2000, Ocean Optics, Dunedin, FL) and a deuterium/halogen lamp
(Model DH-2000, Mikropack GmbH, Germany) coupled with fiber optics
to a 1-cm pathlength quartz cuvette connected to the halothane loop, were
used to monitor the halothane concentration by its optical absorption. The
absorption spectrum of halothane combined with the lamp output resulted
in a working spectrum with a peak at 237 nm. When a steady-state concen-
tration was reached, typically after 1–3 h, the valves were closed, sealing
the canister. As the vapor pressure of halothane is 232 mmHg at 20C,
the concentration of halothane vapor cannot exceed ~1/3 atmosphere, orBiophysical Journal 96(10) 4164–4175a gas-phase concentration of ~16 mM. After reflectivity measurements,
the canister was flushed with moist helium, and the vented gas was directed
to a condenser to trap part of the halothane used and then to exhaust venti-
lation. Readers are cautioned that plastic components in the trough and
oxygen sensor were susceptible to damage from the halothane vapor. The
later experimental run used a trough with all interior components made of
stainless steel or teflon. This run also replaced the conventional Wilhelmy
plate surface pressure transducer used earlier (Riegler & Kirstein, Postsdam,
Germany) with a Wilhelmy plate transducer with a fiber-optic readout devel-
oped in our lab. Additionally, the condenser was replaced with activated
charcoal filters for trapping anesthetic gases (F-Air canisters, Braintree
Scientific, Braintree, MA).
As a practical matter, the change in the transmission of x-rays through the
canister containing the Langmuir trough could determine the relative concen-
tration of halothane vapor in the moist helium atmosphere above the sample.
With the trough lowered out of the path of the beam, the ratio of counts in the
scintillation detector to counts in the ion chamber monitor positioned before
the sample was highest in the absence of halothane and reduced as the halo-
thane concentration increased. This seemed towork better on the first run, and
not as well for the second run, when there seemed to be some instability in the
measurement that caused the ratio to gradually changewith time evenwithout
the introduction of halothane. Similarly, the spectrophotometric determina-
tion of the halothane concentration was made challenging by the length of
time over which baseline stability was required (circa 12 h).
Monolayer preparation
Monolayers were spread from the methanol solution (~100 mM in a-helices)
at the meniscus formed onto a glass capillary penetrating the subphase at an
oblique angle. The subphase contained 1 mM potassium phosphate buffer
with 10 mM KCl, pH 8, maintained at 22C. After the canister was flushed
with moist helium (~20 min), the monolayers were compressed at a constant
speed of ~25 A˚2/a-helix/min to a final area of 100  5 A˚2/helix and held at
fixed area during the reflectivity data collection. The subphase was replaced
completely before spreading a new monolayer.
X-ray reﬂectivity
The liquid surface spectrometer at bending magnet beamline X22-B of the
National Synchrotron Light Source (16,17) (Brookhaven National Labora-
tory, Upton, NY)was usedwith incident x-raywavelength l¼ 1.5275 A˚ (first
set of experiments) or l¼ 1.50625 A˚ (second set) to collect x-ray reflectivity
data as described previously (18). Data were collected over a range of photon
momentum transfer 0.01 < qz < 0.63 A˚
-1. In the first set of experiments, the
trough was translated transverse to the beam by 1 mm, i.e., the width of the
incident x-ray beam, to expose a fresh portion of the sample to the beam after
each reflectivity scan and so avoid any potential radiation damage to the
peptide monolayer. The smaller size of the trough used in the later sets of
experimentsmade this impractical, but the reproducibility of successive scans
under identical conditions appeared comparable, after the initial equilibration
of the monolayer at each condition (see Results and Discussion).
Analysis of reﬂectivity data
The raw data files were reduced using C-Plot (Certified Scientific Software,
Cambridge, MA), including normalization of the reflectivity data by the
Fresnel function to eliminate the effects due to dynamical scattering from
the water-air interface, leaving the kinematical scattering due to the presence
of the peptide monolayer at the interface. Subsequent processing used
Mathematica 4.2 (Wolfram Research, Champaign, IL). Working in the Dis-
torted Wave Born Approximation, we used the so-called box-refinement
algorithm, a model-independent means for solving the phase problem and
obtaining the electron-density profile of the monolayer that accounts for
the observed reflectivity data (19). Differences between the various mono-
layer electron-density profiles obtained from a particular monolayer under
different conditions were computed and then fit with one or a sum of two
Anesthetic-Protein Interaction I 4167Gaussian functions of the form Ai Exp[(z-zi)2/2si2] using the Levenberg-
Marquardt algorithm as implemented in Mathematica’s NonlinearRegress
package (20) with equal weighting for the datapoints. Uncertainties in the
fit parameters are the standard errors obtained from the fits.
RESULTS
As described in the Introduction, we utilized a new peptide,
hbAP1, with only one anesthetic binding cavity near the inter-
face between the hydrophilic and hydrophobic domains
(Ala19), as well as a control peptide with no such cavity,
hbAP1(A19L), in these studies. Solution-based characteriza-
tion techniques show that these peptides solubilized with the
detergent n-octyl b-D-glucopyranoside have properties quite
similar to the parent peptide hbAP0. Circular dichroism indi-
cates helical content in excess of 93% (see Fig. S1 and
Fig. S2 in the Supporting Material). Fluorescence quenching
shows that hbAP1binds halothanewith a dissociation constant
of 2.5  0.2 mM (see Fig. S3). The similarities extend to the
environment of the air/water interface, where both peptides
form stable monolayers with similar pressure-area isotherms
(seeFig. S4).X-ray reflectivity data collected from theseLang-
muir monolayers indicates that the peptide is oriented initially
at low surface pressures with the long axes of the helices
parallel to the air/water interface, whereas upon compression
to high surface pressures and an area/helix approaching 100
A˚2, the helices become oriented with their long axes perpen-
dicular to the interface (see Fig. S5). Grazing incidence x-
ray diffraction data demonstrate that hbAP1 retains its associ-
ation into 4-helix bundles adopting a coiled-coil conformation,
without any further evidence of long-range ordering in the
plane of the monolayer (see Fig. S6). Thus, at high surface
pressures, the amphiphilic 4-helix bundle peptides within the
Langmuirmonolayer are vectorially orientedwith their hydro-
philic domainpenetrating into the aqueous subphase below the
water-air interface and their hydrophobic domain penetrating
into the gaseous superphase above the interface.
Halothane, a halogen-rich electron-dense small molecule,
produces definite and reproducible changes in the reflectivity
of peptide monolayers when introduced into the atmosphere
over the monolayer. Fresnel-normalized reflectivity data
collected from the spread and compressed peptide mono-
layers show a characteristic pattern of maxima and minima
in the range of photon momentum transfer qz < 0.2 A˚
-1
(see Fig. S7 a, black curve), indicating that the helices are
oriented with their long axes approximately normal to the
air/water interface (10). Several successive scans showed
small changes in the reflectivity data before converging to
a pattern stable over subsequent successive scans, each reflec-
tivity scan requiring a total of 60 min. We introduced halo-
thane vapor to the gastight canister containing the trough,
sealing the canister when the spectrophotometer indicated
that the concentration of halothane had reached a steady state.
Reflectivity scans collected at this maximum concentration of
halothane, [halothane]max, showed an increase in the ampli-
tude of this pattern of maxima and minima, but no changein their positions. The three successive scans collected at
[halothane]maxwere all in good agreement towithin the count-
ing statistics (Fig. S7 b). We subsequently purged halothane
from the canister with helium in a stepwise fashion, reducing
the concentration of halothane in the superphase atmosphere
by ~1/2with each step. At each step, reflectivity scans showed
changes in the reflectivity pattern initially that were then
subsequently stable for successive scans. Finally, upon
completion of the purge, the reflectivity data resembles the
data collected before the introduction of halothane, although
the amplitudes of the maxima, particularly the second at
higher qz, do not return entirely to their prehalothane values.
Thus, the changes due to halothane are either not completely
reversible, or insufficient timewas provided despite the repro-
ducibility of successive scans to within the noise level of the
counting statistics (see Discussion).
The box-refinement algorithm allows us to determine from
the Fresnel-normalized reflectivity data the electron-density
profile of the monolayer at each concentration of halothane
and thereby observe the changes due to the presence of halo-
thane. Fig. 1 shows representative electron-density profiles
obtained for the hbAP1 monolayer at each concentration of
halothane investigated in the first set of experiments. The
profile, r(z), is the projection of the three-dimensional elec-
tron density of the monolayer, r(r), parallel to the plane of
FIGURE 1 Electron-density profiles of the hbAP1 monolayer at the
different concentrations of halothane established in the first set of dissociation
experiments. Prehalothane (black), maximal halothane of [halothane]max
(red); and (1/2) [halothane]max (blue); [halothane]¼ zero after the final purge
(cyan). Juxtaposed above the profiles is a schematic representation of the
Langmuir monolayer of hbAP1 peptide bundles, approximately to scale.Biophysical Journal 96(10) 4164–4175
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ular to the plane of the interface. The electron density profile is
averaged spatially over the plane of the monolayer azimuth-
ally about the z axis, and temporally over the time of the
data collection, varying from a few seconds to ~1 min per
data-point. Fig.S8 shows the 2–3 profiles obtained sequen-
tially from that same hbAP1 monolayer at each of four
different experimental conditions, as well as the correspond-
ing 1–2 difference profiles between successive profiles at each
condition. The phased Fourier transform in the algorithm
resulting in these profiles is necessarily truncated for
momentum transfer values exceeding qz
max, the point beyond
which the Fresnel-normalized reflectivity data from the
peptide monolayer at the water-helium interface becomes
identical to that for the interface in the absence of the peptide
monolayer to within the photon counting-statistics noise
level. Truncation of the transform at qz
maxz 0.5 A˚-1 in this
work results in the profiles containing a low amplitude,
high-frequency component (or ‘‘ripple’’) of wavelength
~15A˚ (defining the ‘‘spatial resolution’’ of the profiles),
whose mean value defines the local average electron density
over any particular region of the profile exceeding this
minimum wavelength. The 2–3 electron-density profiles
calculated for the monolayer at each condition can be seen
to be identical to within the amplitude of this high-frequency
ripple over the entire extent of the monolayer profile in
Fig. S8. The difference electron-density profiles calculated
between two successive profiles at each condition exhibit
only the high-frequency ripple component fluctuating about
a mean of zero, or near zero, electron density over the entire
extent of the monolayer profile, the amplitude of these fluctu-
ations being less than the twice the amplitude of those in each
profile, once equilibration at each condition has been fully
achieved. Thus, for difference profiles calculated between
two profiles for which the monolayer is fully equilibrated at
two different conditions to be significant, they must therefore
exhibit features of greater amplitude and lower frequency than
those evident in this figure.
Inspection of the electron-density profiles reveals features
common to all the profiles. The profile obtained before the
introduction of halothane exhibits a rise in electron density
from the (zero) density of the vapor phase to that of the mono-
layer with the peptide/vapor interface arbitrarily positioned at
z¼ 0 A˚, a region of nearly constant density extending to about
z¼50 A˚, and then a transition to the density of the aqueous
subphase (0.333 e-/A˚3, which becomes 1 in the reduced elec-
tron-density profiles r(z)/rH2O as shown) representing the
peptide/subphase interface. The center of this latter interfacial
feature in the profiles is near z ¼ 60 A˚, consistent with
the expected length of the peptide, comprised of 37-residue
a-helices with a 3-residue flexible loop. The uniformity of
the electron density over the central portion of the profile struc-
ture indicates that virtually all of the peptides in themonolayer
are oriented with their long axes normal to the air-water
interface. There are also differences between the profilesBiophysical Journal 96(10) 4164–4175obtained under different conditions. The thickness of the
monolayer does not change as halothane is introduced, but
the density increases as the concentration of halothane
increases. A more subtle difference is that both the interface
between the monolayer and the subphase and the interface
between the monolayer and the superphase become sharper.
This makes the density in the central region more constant
over a broader region and while also increasing the density
in a narrow region closest to the superphase. Because these
effects are apparent in all the profiles that have been exposed
tomaximal halothane,we obtain themost consistent results by
comparing the profiles obtained in the presence of halothane
with the profile obtained after halothane has been purged
from the sample chamber (seeDiscussion).As the amphiphilic
4-helix bundle peptide is retained in themonolayer at constant
area/helix during the experiment, the changes in electron
density within the monolayer electron-density profile are
assumed to arise primarily from the introduction of the elec-
tron-dense halothane into the monolayer (see below).
Computing differences between the electron-density
profiles of the hbAP1monolayer obtained at different concen-
trations of halothane allows us to visualize better the changes
due to halothane and to quantify them (Fig. 2). These differ-
ences show that different parts of the peptide bundle have
differing affinities for halothane. The difference between the
profiles at [halothane]max and [halothane] ¼ 0 after the final
purge, namely the distribution of maximal halothane bound
to the monolayer in this first set of experiments, shows that
halothane is broadly distributed nearly uniformly across the
entire length of the bundle. However, the difference between
the profiles at [halothane]max and (1/2)[halothane]max, which
corresponds to the halothane removed in the first purge, is
strongly asymmetrically distributed with a larger fraction
of the halothane removed from the region 25 < z < 0 A˚
occupied by the hydrophobic domain of the bundle, and
the remainder removed from the hydrophilic domain over
the region 60 < z < -25 A˚. Conversely, the difference
between the profiles at (1/2)[halothane]max and 0, correspond-
ing to the halothane removed in the second and final purge in
this set of experiments, shows a broad symmetric distribution
centered at z ¼ 35 A˚. So in this first set of dissociation
experiments, halothane is initially present throughout the
bundle at the highest concentration of halothane. During the
first purge, most of the halothane present in the hydrophobic
domain nearest the vapor phase, and some of the halothane
present in the hydrophilic domain of the bundle leaves. The
halothane remaining after the first purge is symmetrically
distributed about a point near the center of the bundle in
the vicinity of the designed cavity. All of these differences
contain larger amplitude, low-frequency components com-
pared to the differences between profiles obtained at each
of the same concentrations of halothane after the structure
stabilized (see Discussion). As a representative example, the
difference between the first two reflectivity scans collected
at [halothane]max also appears in Fig. 2 d.
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trough, increasing the steady-state level of [halothane]max
and resulting in the introduction of more halothane into the
FIGURE 2 Differences between the electron-density profiles for the
hbAP1 monolayer shown in Fig. 1 for the different halothane concentra-
tions: (a) [halothane]max [zero]; (b) [halothane]max (1/2) [halothane]max;
and (c) (1/2)[halothane]max  [zero]. (d) The difference between electron-
density profiles obtained from two successive reflectivity scans at the
same concentration, [halothane]max, shows the level of uncertainty in the
differences arising from truncation errors (see Discussion and Fig. S8).
Dashed black curves show the nonlinear least-squares fits of Gaussian func-
tions to the difference profiles, with a black solid curve representing the sum
of the Gaussians when two were used. The violet stripe running through the
figures indicates the expected position of Ala19, the residue forming the
designed binding cavity for halothane, illustrated schematically in the model
juxtaposed above the figure.peptide bundles. Fig. 3 shows the electron-density profiles
obtained from an hbAP1 monolayer using the later setup.
The ordinate scale of the difference profiles (Fig. 4, left
side) makes it clear that roughly twice as much halothane
is present in the monolayer for these measurements as for
the first set (Fig. 2). The difference between the profiles at
[halothane]max and [halothane] ¼ 0 after the final purge,
namely the distribution for this higher maximal concentra-
tion of halothane bound to the monolayer in the second set
of experiments, shows that halothane is again broadly
distributed across the entire length of the bundle, but asym-
metrically with an even larger amount within the hydro-
phobic domain (Fig. 4 a). The latter arises, most likely,
from the available nonpolar environment of the space
between the closely packed hydrophobic domains of the
bundles within the monolayer adjacent the gaseous super-
phase. These difference profiles show that after this higher
maximal concentration of halothane in the bundle, halothane
leaves the hydrophobic domain and subphase end of the
hydrophilic domain of the bundle and becomes more
concentrated in the center of the bundle as a result of the first
purge (Fig. 4 b). Again, most, but not all, of the halothane
remaining after the first purge is symmetrically distributed
about a point near the center of the bundle in the vicinity
of the designed cavity; although there is more halothane
within this distribution than for the prior set of experiments
based on the electron-density level, and some halothane
remains within the hydrophobic domain (Fig. 4 c).
Results from a monolayer of the control peptide, hbAP1
(A19L) possessing no cavity, using the later setup for the
second set of experiments, also show changes due to the
presence of halothane in the monolayer, but with a distinctly
different pattern of dissociation during the stepwise purge.
Fig. 4 (right side) shows differences between the electron-
density profiles obtained at different concentrations of
FIGURE 3 Electron-density profiles of the hbAP1 monolayer at the
different concentrations of halothane established in the second set of
dissociation experiments. Prehalothane (black), maximal halothane of
[halothane]max (red); (1/2) [halothane]max (blue); and [zero] halothane after
the final purge (cyan). [halothane]max is ~2-fold higher than that for the first
set shown in Fig. 1.Biophysical Journal 96(10) 4164–4175
4170 Strzalka et al.FIGURE 4 Differences between the electron-density
profiles for the hbAP1 monolayer shown in Fig. 3 for the
different halothane concentrations: (a) [halothane]max 
[zero]; (b) [halothane]max  (1/2) [halothane]max; and (c)
(1/2) [halothane]max  [zero]. Differences between the
profile structures of the control hbAP1(A19L) peptide
monolayer shown in Fig. 5: (d) [halothane]max  [zero];
(e) [halothane]max  (2/3) [halothane]max; (f) (2/3)
[halothane]max  (1/3) [halothane]max ; and (g) (1/3)
[halothane]max  [zero]. Dashed black curves show the
nonlinear least-squares fits of Gaussian functions to the
difference profiles, with a black solid curve representing
the sum of the Gaussians when two were used. The stripe
running through the figures indicates the expected position
of residue 19, which is an Ala residue forming the designed
binding cavity for halothane in hbAP1 and a Leu in the
control peptide hbAP1(A19L).halothane that are all effectively uniform over the length of
the peptide bundle (only the profiles themselves are shown
in Fig. 5). Measurements for the control peptide in this
second set of experiments included a third purge that reduced
the amount of halothane present to a quantity comparable to
that for hbAP1 in the first set of experiments. (Compare
Fig. 4 gwith Fig. 2, and note that they have the same ordinate
scale.) However, even though the amplitude of the difference
profile shown in Fig. 4 g is comparable to the difference
in Fig. 2 c, the distributions are still distinctly different.
The distribution of halothane in the control peptide at this
final purge (Fig. 4 g) is similar to the distribution of the
maximal halothane present in the earlier hbAP1 measure-
ment (Fig. 2 a), namely effectively uniformly distributed
over the length of the bundle and not distributed symmetri-
cally about a single point as in the final purge of the
hbAP1 peptide (Fig. 2 c). So although the distribution of
halothane in hbAP1(A19L) at [halothane]max is similar to
that for hbAP1, namely a uniform distribution along the
bundle, the intermediate results from the stepwise purges
of halothane do not show any evidence that any part of the
hbAP1(A19L) peptide bundle has a higher affinity for halo-
thane than any other part. In particular, note that the presence
of residues with aromatic side-chains, Trp15 and Phe12, in
this control peptide does not result in any localization of
halothane along the length of the bundle.
FIGURE 5 Electron-density profiles of the hbAP1(L19A) monolayer at
the different concentrations of halothane established in the second set of
dissociation experiments. Prehalothane (black), maximal halothane of [hal-
othane]max (red), (2/3) [halothane]max (blue) (1/3) [halothane]max (magenta),
and [zero] halothane after the final purge (cyan). [halothane]max is ~2-fold
higher than that for the first set shown in Fig. 1.Biophysical Journal 96(10) 4164–4175
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Our approach is based on the analysis of the electron-density
profiles obtained for each Langmuir monolayer of an amphi-
philic 4-helix bundle peptide as it is subjected to a sequence
of experimental conditions, namely before exposure to halo-
thane, followed by exposure to a maximal concentration of
halothane vapor in the superphase, and subsequently to step-
wise purging of the halothane in the superphase back to zero
concentration. Difference electron-density profiles calculated
for any two profiles for which the monolayer was equilibrated
at any one particular condition exhibited only the high-
frequency ripple component fluctuating about a mean of
zero, or near-zero electron density, over the entire extent of
themonolayer profile, the amplitude of these fluctuations being
less the twice the amplitude of those in each profile. These
difference profiles at any one particular condition thereby
establish the level of uncertainty in such difference profiles.
For difference electron-density profiles calculated for any
two profiles for which the monolayer was equilibrated at
two different conditions to be deemed significant, they must
therefore contain lower frequency features of wavelength
greater than that of the high-frequency truncation ripplewhose
amplitude exceeds twice the amplitude of this ripple present
in each profile. Importantly, having at least two profiles
fully equilibrated at each condition provides a minimum of
four (22) independent difference electron-density profiles
between any two different conditions. The high degree of
similarity of such significant features among these four inde-
pendent difference profiles for all of the cases described in this
work clearly demonstrate the reproducibility or robustness of
these features.
As noted in Results, comparison of the electron-density
profiles for the peptide monolayer fully equilibrated before
exposure to maximal halothane with those after exposure to
maximal halothane and subsequently purged stepwise to
zero halothane concentration shows a small but significant
irreversible effect of halothane exposure on the monolayer
structure. This comparison suggests that exposure tomaximal
halothane results in a better interbundle ordering within the
monolayer. Specifically, all helices become perpendicular to
the water-air interface resulting in the profiles becoming
more perfectly uniform over the helices’ expected 60 A˚
length and all bundles become more in-register over the
monolayer plane, thereby significantly sharpening particu-
larly the peptide-water interface and the peptide-gas interface
at either end of the bundle. As a result of this reproducible
effect ofmaximal halothane exposure on interbundle ordering
within the monolayer, we have more closely examined only
comparisons between the electron-density profiles obtained
at finite concentrations of halothane with those obtained at
zero halothane concentration achieved after stepwise purges
from maximal halothane concentration.
Integration of the difference electron-density profiles in
Figs. 2 and 4 allows an estimate of the amount of halothanepresent in the peptide monolayer. The scale for these results
arises from a comparison of the electron densities of halothane
and water. Each halothane molecule has 92 electrons in
a characteristic volume of 123 A˚3 (7,21), and the 10 electrons
of each water molecule occupy a characteristic volume of
27.8 A˚3 (21). With the monolayer maintained at a constant
area of 100 A˚2/helix during the reflectivity measurements,
the in-plane density of protein in the monolayer remains
constant and only water, halothane and helium are free
to leave the monolayer and equilibrate with the aqueous
subphase below and the gaseous superphase above the mono-
layer. (We do not expect halothane to affect the distribution of
the ions present in the buffered subphase.) Each halothane
molecule that enters the monolayer could displace 4.43 water
molecules, resulting in a net increase of 47.7 electrons in the
monolayer. This assumption will result in the integration
producing a maximal number of halothane molecules per
bundle. However, the nonpolar core of the hydrophilic
domain in such 4-helix bundles is very dynamic, as estab-
lished by NMR studies and molecular dynamics simulations
(9,14,22), and some space may also remain available between
the closely packed hydrophobic domains in the monolayer.
Thus, halothane could displace only vacuumor helium instead
of water, thereby resulting in an overestimate in the number of
halothane molecules per bundle, but by less than a factor of 2.
Considering the hbAP1 measurements at lower maximal
halothane concentration achieved in the first set of experi-
ments (with profile structures shown in Fig. 1), integration
of the differences between profile structures obtained at
the same concentration of halothane shows values of 0  5
e/helix, so we can consider this the noise level in these
estimates. This uncertainty can be expressed in terms of halo-
thane as 0 0.1 halothane/helix, or because these are 4-helix
bundles, 0  0.4 halothane/bundle. Integrating the differ-
ences between profile structures for the monolayer under
different concentrations of halothane shows much larger
differences in the number of electrons/helix. Relative to the
profile structure at [halothane] ¼ 0, the hbAP1 monolayer
at [halothane]max contains ~70 excess electrons/helix, corre-
sponding to ~1.6 halothane molecules/helix, or ~6–7 halo-
thanes/bundle. Roughly 40% of these electrons (about three
halothane molecules) leave the monolayer in the first purge,
leaving 3–4 halothane molecules/bundle symmetrically
distributed about a single maximum (Fig. 2 c). The second
set of experiments with higher concentrations of maximal
halothane achieved as many as 12–18 halothane mole-
cules/bundle for hbAP1 and hbAP1(A19L) at [halo-
thane]max, and as few as ~3 halothane molecules/bundle
for the hbAP1(A19L) monolayer at the last purge.
Fitting simple curves to the significant features (as defined
above) within the difference electron-density profiles helps
also to better quantify spatial aspects of the halothane distribu-
tion within the monolayer. Either a symmetric unimodal
distribution, represented by a single Gaussian function, or
a symmetric (or asymmetric) bimodal distribution, representedBiophysical Journal 96(10) 4164–4175
4172 Strzalka et al.by the sumof twoGaussians, can describe themain features of
the difference profiles in most cases for the hbAP1monolayer.
We used both a global chi-squared parameter and the uniform
distribution of residuals over the profile coordinate to establish
the goodness of these fits. The fitting algorithm provided both
the mean values of the parameters and their uncertainties
for the so-fitted one or two Gaussian functions. Considering
the first set of experiments for hbAP1 (Fig. 2), the difference
between the profiles at [halothane]max and [halothane]¼ 0 rep-
resenting the distribution of halothane along the bundle at
maximal halothane achieved in the first set of experiments,
can be approximated by amildly asymmetric bimodal distribu-
tion, the two Gaussians of nearly equal amplitudes and widths
summing to provide a fairly uniform distribution of halothane
along the length of the bundle. The halothane that leaves
during the first purge can be represented by a strongly asym-
metric bimodal distribution that has a narrower component
centered about z1 ¼ 14.5 A˚ within the hydrophobic domain
and a broader component centered about z2 ¼ 38 A˚ within
the hydrophilic domain. The areas of the two components
are nevertheless comparable. The halothane that leaves
during the second purge can be fit with a symmetric unimodal
distribution, the single broad Gaussian centered about
z¼35 1 A˚. Locating residue Cys40 at the air/water inter-
face (z ¼ 0 A˚), and treating all the residues according to the
expected rise/residue in an a-helix of 1.5 A˚, we expect Ala19
to be between 33 < z < 31.5 A˚. The observed center of
the halothane distribution is very close to the expected position
of Ala19 but shifted slightly in the direction of Trp15 (expected
to be at39< z<37.5 by the same logic). The full 1/ewidth
of the distribution, 76 3 A˚, is much broader than the spatial
resolution of the experiment. By comparison, in a resonance
x-ray reflectivity measurement on a Langmuir monolayer
with a covalently bound resonant atom, 2-bromo-stearic
acid, the contribution of the resonant Br atom could be local-
ized as a single Gaussian with a full 1/e width of ~8 A˚
(2
ﬃﬃﬃ
2
p
s, s ¼ 3 A˚), namely about the same as the observed
roughness of a clean air-water interface (15). In that experi-
ment, the range over which data was collected was about the
same, but significant components of the data existed out to
somewhat higher qz ¼ 0.6 A˚-1. Thus, if the hbAP1 peptide
bundles in the Langmuir monolayer were to contain a single
halothane very tightly bound with a well-defined position
along the length of the bundle, we would expect to see a distri-
bution not much larger than the expected size of the halothane
molecule (e.g., ~7 A˚). Because all of the bundles are effec-
tively identical, both in their composition and their location/
orientation with respect to the water-air interface, the broad
distribution is mostly likely dynamic in origin, with halothane
showing an increased probability to be localized about the site
of the designed binding cavity, but nevertheless capable of
translational motion along the core of the bundle.
Even though our dissociation experiments did not study
the peptide-halothane complex at a stoichiometry of 1 halo-
thane/4-helix bundle, we see evidence after the first purge ofBiophysical Journal 96(10) 4164–4175halothane from the hbAP1 monolayer that the remaining
3–4 halothanes left in the bundle are distributed with the
maximum probability centered on the site of Ala19, whose
small side chains were intended to form the binding cavity
in the bundle. In contrast, the measurements with the control
peptide hbAP1(A19L) after two purges reach only approxi-
mately three halothanes/bundle, but this smaller amount of
halothane still is not localized at a single site in the bundle.
The distribution of these halothane molecules over the length
of the hbAP1(A19L) bundle can be fit with a mildly asym-
metric bimodal distribution like that for hbAP1 at six to
seven halothane molecules per bundle, the two Gaussians
summing to provide a fairly uniform distribution of halo-
thane along the length of the bundle. Thus, these dissociation
experiments provide the first direct structural evidence in
support of this approach to designing anesthetic binding
cavities since the photoaffinity labeling results for soluble
peptides (8).
The behavior of hbAP1 in the second set of dissociation
experiments deserves some further comment. The results
from the first set of experiments for hbAP1 at the maximal
level of halothane incorporated into the monolayer indicated
a nearly uniform distribution of halothane over the length of
the bundle, effectively modeled as a mildly asymmetric
bimodal distribution, at six to seven halothane molecules
per bundle, as described above. It then may seem surprising
that the first purge in the second set results to first approxima-
tion in a near unimodal distribution of halothane centered
about the designed cavity location, even though the halo-
thane concentration in the monolayer was at a somewhat
higher level than six to seven molecules/bundle. However,
the distribution is obviously bimodal in fact with a substantial
second component within the hydrophobic domain, and this
may provide a second indication that our protocol has not
allowed sufficient time to fully establish an equilibrium
situation, despite the invariance achieved for successive
reflectivity scans at each halothane concentration to within
the experimental noise level. Nevertheless, this result may
be an indication that the somewhat higher affinity of the
designed cavity for halothane within hbAP1, compared
with the nonpolar core of the bundle, can tend to localize
halothane in the vicinity centered about the position of the
cavity even at higher concentrations within the bundle
when challenged with a purge under nonequilibrium condi-
tions. Again, it is important to note that the control peptide
lacking only the cavity exhibited only an essentially uniform
distribution of halothane over the entire length of the bundle,
with no such evidence of any localization under otherwise
identical conditions when challenged with purges at these
higher halothane concentrations within the bundle.
One aspect of the work described above has recently been
improved via a halothane ‘‘association’’ experiment. Instead
of exposing the peptide monolayer to maximal halothane
in the moist helium atmosphere above the monolayer
followed by a stepwise purge, we exposed a fully equilibrated
Anesthetic-Protein Interaction I 4173monolayer of hbAP1 to a halothane concentration anticipated
to result in closer to only onemolecule per bundle based on the
previous experiments. After equilibration at that lower
concentration, the halothane in the atmosphere was again
subsequently purged to zero. The difference electron-density
profile calculated between the electron-density profile for the
monolayer fully equilibrated at that lower halothane concen-
tration and that after the purge is shown in Fig. 6. Integration
of this difference profile indicated that the average halothane
concentration per 4-helix bundle was indeed only slightly
greater than one (e.g., ~1.1). This difference profile is asym-
metric, has narrower full-width, and ismore peaked compared
to the symmetric difference profile for three to four halothane
molecules per bundle shown in Fig. 2 c. Specifically, the full-
width of the difference profile at about one halothane mole-
cule per bundle is only ~42 A˚ compared with ~76 A˚ at three
to four halothane molecules per bundle. At about one halo-
thane per bundle, the halothane distribution is more peaked
due to narrow component centered at z ~ 36  2 A˚, also
near the expected location of the cavity long the length of
the bundle, with a full-width of only 2
ﬃﬃﬃ
2
p
s ~19  3 A˚. This
suggests that the halothane is becoming even more localized
to the near vicinity of the cavity along the length of the bundle
as the average halothane/bundle stoichiometry is reduced.
Nevertheless, the width of the distribution even within this
narrower component still exceeds halothane’s diameter by
a factor of ~2–3. Importantly, analogous difference elec-
tron-density profiles for the control peptide hbAP1(A19L)
still show only a nearly uniform distribution of halothane
over the entire length of the bundle, even at this lower level
of halothane in the monolayer achieved in these association
experiments. Finally, similar results were obtained in these
association experiments utilizing hbAP-PheCN, a mutant of
the hbAP1 peptide utilized in parts II and III under this title
in which Trp15 was replaced by cyano-phenylalanine to
thereby enable an investigation of halothane binding via
infrared spectroscopy (see Fig. 6).
In future work, we plan to utilize a newly developed inter-
ferometric technique, using an inorganic, solid multilayer
reference structure in the aqueous subphase positioned suffi-
ciently close to (e.g., to within 50–100 A˚), but not in contact
with the peptidemonolayer. Thiswill provide for a substantial
enhancement in sensitivity to the presence of halothanewithin
the profile structure of the model ion channel protein and
a substantial extension in the spatial resolution of the profile
to well below 10 A˚ (V. Krishnan, J. Strzalka, J. Liu, C. Liu,
I. Kuzmenko, T. Gog, and J. K. Blasie, unpublished data).
CONCLUSIONS
The simplicity of the lipid-free model membrane protein
system, vectorially oriented in Langmuir monolayers at the
air-water interface, allows us to unambiguously study the
protein/anesthetic interaction. This interaction showed
different characteristics depending on the peptide and theFIGURE 6 Differences (dotted lines) between the electron-density profiles
for the hbAP1 and hbAP-PheCN monolayers at different halothane concentra-
tions in the recent association experiments. (a) (1/2) [halothane]max [zero] for
hbAP1 from the dissociation experiment shown in Fig. 2 c and again here for
comparison. (b) [Halothane]one/bundle [zero] for hbAP1; and (c) [halothane]
one/bundle  [zero] for hbAP-PheCN. [Halothane]one/bundle denotes the
concentration of ~1–1.5 halothane molecules per 4-helix bundle achieved in
the association experiments. The black dashed curves show the nonlinear
least-squares fits of Gaussian functions to the difference profiles, with a black
solid curve representing the sum of the Gaussians when two were used. The
gray stripe running through the figures indicates the expected position of
Ala19, the residue forming the designed binding cavity for halothane. The lower
concentration of approximately one halothane molecule per bundle achieved in
the association experiments results in no halothane remaining in the hydrophobic
domainextendingover20A˚< z<0A˚.Theadditional features near thepeptide-
gas interface at z¼ 0 A˚ in the difference profile shown in panel b arise from the
reversible effect of halothane on the width of the peptide-gas interface in this
association experiment with hbAP1. The full-width of the halothane distribution
for hbAP1 in panel bwas calculated from the best-fit parameters of twoGaussian
functions as ðz1 z2Þ þ ﬃﬃﬃ2p ðs1 þ s2Þ. See Discussion for further details.Biophysical Journal 96(10) 4164–4175
4174 Strzalka et al.relative concentration of halothane. In the control peptide,
and in the target peptide possessing a designed cavity, at
higher concentrations, halothane was found to be present
throughout the length of the bundle, associating with the resi-
dues forming the core of the bundle. In the target protein at
lower concentrations of halothane, the distribution of halo-
thane became localized in a broad unimodal distribution
centered about the Ala residues specifically designed to
form a cavity for binding anesthetics in the core of the
bundle. This rich behavior follows as a consequence of the
thermodynamics discussed previously, where the dissocia-
tion constant of the peptide for halothane is so large that
the energetics of the association are only marginally better
than those implied by the partition coefficient of the anes-
thetic into a nonpolar medium. Because the dissociation
constant of these model peptides is close to the range of
physiologically relevant anesthetic concentrations, it is likely
that this weak association interaction is shared by many
proteins in vivo. The ability of x-ray reflectivity to detect
and locate halothane within the profile structure of the mono-
layer despite the inherent disorder of the ligand in the system
underlines its advantages over other techniques for structural
characterization. For example, solution-based NMR and
especially x-ray crystallography are not capable of detecting
protein ligands with such inherent positional disorder.
This study also establishes the viability of our model
membrane protein system for studying anesthetic-protein
interactions, suitable as a platform for other complementary
techniques. These synthetic peptides can easily accommo-
date nonbiological amino acids serving as labels for
polarized infrared spectroscopic measurements on oriented
samples. For instance, cyano-phenylalanine has already
been substituted for the Trp in hbAP1 and used to probe
the local interactions between halothane and the amino-
acid residues via fluorescence and polarized vibrational
spectroscopy in samples that have also been similarly char-
acterized structurally by x-ray scattering (13). Interpretation
of the results was enabled by utilization of molecular
dynamics simulations affording a three-dimensional view
of the peptide structure at atomic resolution otherwise unat-
tainable experimentally (14). Similarly, deuterium-labeled
amino acids can also be incorporated into the peptides at
specific sites and neutron reflectivity studies of monolayers
prepared from a family of 2H-labeled but otherwise isomor-
phous peptides could allow determination of the positions
of individual residues within the profile structure of the
monolayer (23). These positions could in turn validate or
constrain molecular dynamics simulations yielding three-
dimensional structures consistent with the projections
observed in the reflectivity measurements.
SUPPORTING MATERIAL
Figures S1–S8 referenced in the text are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(09)00608-0.Biophysical Journal 96(10) 4164–4175We thank BenjaminM. Ocko andMasafumi Fukuto of the Soft Matter Group
in the Department of Condensed Matter Physics and Material Science,
Brookhaven National Laboratory, for the use of their trough and assistance
at beamline X22-B. We thank Elaine DiMasi of the National Synchrotron
Light Source for the use of her trough and help setting it up. We also thank
Scott Coburn for technical assistance at X22-B, Mike Sullivan for use of
the support lab of the Case Center for Synchrotron Biosciences, William
Pennie of the Research Instrumentation Shop at the University of
Pennsylvania for helpful discussions, Venkata Krishnan for assistance with
data collection, Shixin Ye for preliminary work with the peptides, and Ivan
Kuzmenko and Thomas Gog for assistance with the grazing incidence
x-ray diffraction measurements at Sector 9 of the Advanced Photon Source.
This work was supported by the National Institutes of Health under
GM55876. Use of the National Synchrotron Light Source, Brookhaven
National Laboratory, was supported by the U.S. Department of Energy,
Office of Science, Office of Basic Energy Sciences, under contract No.
DE-AC02-98CH10886. Use of the Advanced Photon Source was supported
by the U.S. Department of Energy, Office of Science, Office of Basic Energy
Sciences, under contract No. DE-AC02-06CH11357.
REFERENCES
1. Koblin, D. D. 2001. Structure-activity relationships of inhaled anes-
thetics. In Molecular Bases of Anesthesia. E. Moody and P. Skolnick,
editors. CRC Press, Boca Raton, FL. 123–145.
2. Dilger, J. P. 2001. Basic Pharmacology of Volatile Anesthetics. In
Molecular Bases of Anesthesia. E. Moody and P. Skolnick, editors.
CRC Press, Boca Raton, FL. 1–35.
3. Franks, N. P., and W. R. Lieb. 1994. Molecular and cellular mecha-
nisms of general-anesthesia. Nature. 367:607–614.
4. Miyazawa, A., Y. Fujiyoshi, M. Stowell, and N. Unwin. 1999. Nicotinic
acetylcholine receptor at 4.6 angstrom resolution: transverse tunnels in
the channel wall. J. Mol. Biol. 288:765–786.
5. Liu, R. Y., P. J. Loll, and R. G. Eckenhoff. 2005. Structural basis for
high-affinity volatile anesthetic binding in a natural 4-helix bundle
protein. FASEB J. 19:567–576.
6. Robertson, D. E., R. S. Farid, C. C. Moser, J. L. Urbauer, S. E. Mulhol-
land, et al. 1994. Design and synthesis of multi-heme proteins. Nature.
368:425–431.
7. Johansson, J. S., B. R. Gibney, F. Rabanal, K. S. Reddy, and
P. L. Dutton. 1998. A designed cavity in the hydrophobic core of
a four-alpha-helix bundle improves volatile anesthetic binding affinity.
Biochemistry. 37:1421–1429.
8. Johansson, J. S., D. Scharf, L. A. Davies, K. S. Reddy, and R. G. Eck-
enhoff. 2000. A designed four-alpha-helix bundle that binds the volatile
general anesthetic halothane with high affinity. Biophys. J. 78:982–993.
9. Cui, T. X., V. Bondarenko, D. J. Ma, C. Canlas, N. R. Brandon, et al.
2008. Four-alpha-helix bundle with designed anesthetic binding
pockets. Part II: halothane effects on structure and dynamics. Biophys.
J. 94:4464–4472.
10. Ye, S. X., J. Strzalka, I. Y. Churbanova, S. Y. Zheng, J. S. Johansson,
et al. 2004. A model membrane protein for binding volatile anesthetics.
Biophys. J. 87:4065–4074.
11. Lear, J. D., Z. R. Wasserman, and W. F. Degrado. 1988. Synthetic
amphiphilic peptide models for protein ion channels. Science.
240:1177–1181.
12. Churbanova, I. Y., A. Tronin, J. Strzalka, T. Gog, I. Kuzmenko, et al.
2006. Monolayers of a model anesthetic-binding membrane protein:
formation, characterization, and halothane-binding affinity. Biophys.
J. 90:3255–3266.
13. Liu, J., J. Strzalka, A. Tronin, J. S. Johansson, and J. K. Blasie. 2009.
Mechanism of interaction between the general anesthetic halothane
and a model ion channel protein, II: fluorescence and vibrational
spectroscopy using a cyanophenylalanine probe. Biophys. J. 96:4176–
4187.
Anesthetic-Protein Interaction I 417514. Zou, H., J. Liu, and J. K. Blasie. 2009. Mechanism of interaction
between the general anesthetic halothane and a model ion channel
protein: III. Molecular dynamics simulation incorporating a cyanophe-
nylalanine spectroscopic probe. Biophys. J. 96:4188–4199.
15. Strzalka, J., E. DiMasi, I. Kuzmenko, T. Gog, and J. K. Blasie. 2004.
Resonant x-ray reflectivity from a bromine-labeled fatty acid Langmuir
monolayer. Phys. Rev. E. 70:051603.
16. Weiss, A. H., M. Deutsch, A. Braslau, B. M. Ocko, and P. S. Pershan.
1986. Novel x-ray diffractometer for liquid surface studies. Rev. Sci.
Instrum. 57:2554–2559.
17. Braslau, A., P. S. Pershan, G. Swislow, B. M. Ocko, and J. Als-Nielsen.
1988. Capillary waves on the surface of simple liquids measured by
x-ray reflectivity. Phys. Rev. A. 38:2457–2470.
18. Strzalka, J., X. X. Chen, C. C. Moser, P. L. Dutton, B. M. Ocko, et al.
2000. X-ray scattering studies of maquette peptide monolayers. 1. Re-
flectivity and grazing incidence diffraction at the air/water interface.
Langmuir. 16:10404–10418.19. Blasie, J. K., S. Zheng, and J. Strzalka. 2003. Solution to the phase
problem for specular x-ray or neutron reflectivity from thin films on
liquid surfaces. Phys. Rev. B. 67:224201.
20. WolframResearch 1999. Statistics ‘NonlinearFit’. In Mathematica 4
Standard Add-on Packages. E. Martin and J. Novak, editors. Wolfram
Media, Champaign, IL. 476–483.
21. Abraham, M. H., and J. C. McGowan. 1987. The use of characteristic
volumes to measure cavity terms in reversed phase liquid-chromatog-
raphy. Chromatographia. 23:243–246.
22. Ma, D. J., N. R. Brandon, T. X. Cui, V. Bondarenko, C. Canlas, et al.
2008. Four-alpha-helix bundle with designed anesthetic binding
pockets. Part I: structural and dynamical analyses. Biophys. J.
94:4454–4463.
23. Strzalka, J., B. R. Gibney, S. Satija, and J. K. Blasie. 2004. Specular
neutron reflectivity and the structure of artificial protein maquettes vec-
torially oriented at interfaces. Phys. Rev. E. 70:061905.Biophysical Journal 96(10) 4164–4175
